OS Therapies Inc (OSTX) stock

OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30

$0.74−0.01 (-0.68%)

Close on Nov 13, 2026Market cap $34.36MP/E –Yield –

OS Therapies gross margin

Gross margin is gross profit as a percentage of revenue.

OS Therapies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?